RPS6KB1 and breast cancer: Altogether, our in vitro and in vivo data suggest that interfering with p70S6K activity with FS-115 in peri-surgical schedule or in long-term treatment regimen may represent reliable strategies to treat breast cancer patients at high risk to develop locoregional recurrence and distant organ metastasis.